India, Oct. 13 -- Retail giant Walmart (WMT) has announced that it will introduce several healthcare and employee benefit enhancements for its 1.6 million U.S. associates beginning in 2027, including a new zero-dollar prescription tier, specialist care for rare conditions and paid neonatal intensive care unit (NICU) leave.
The prescription benefit will cover more than 250 generic, brand-name and specialty medications, including certain insulin products and inhalers. Associates with Type 2 diabetes will also have access to eligible GLP-1 medications at no cost.
Walmart is expanding its Centers of Excellence program with a Rare Conditions Center of Excellence, offering eligible associates and dependents covered by most medical plans no-cost...